The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting.
Giovanni TisciaGiovanni FavuzziAntonio De LaurenzoFilomena CappucciLucia FischettiDonatella ColaizzoElena ChinniLucia FlorioGiuseppe MiscioAngela Pamela PiscitelliMario MastroiannoElvira GrandonePublished in: Diagnostics (Basel, Switzerland) (2021)
The present findings show that in COVID-19, the VWF/ADAMTS-13 fraction predicts in-hospital mortality. The VWF/ADAMTS-13 fraction may be a helpful tool to monitor COVID-19 patients throughout hospitalization.